StemCell Medicine

9 Small Businesses Awarded Scholarships to Attend International BIO Convention

MADISON, Wis.–(BUSINESS WIRE)– Nine Wisconsin biotechnology companies have been awarded scholarships to support attending the Biotechnology Industry Organizations (BIO) International Convention in Boston, MA. June 18-21, 2012. All recipients plan to participate in BIOs one-on-one partnering with potential customers from around the world, or to present to potential investors Continue reading →

Posted in Biotechnology | Tagged a-wide-variety, biotechnology, boston, business, clinic-applied, compounds-based, development, diseased-cells-, financial-need-, international, organizations, recipients-are, recipients-plan, ribonuclease, wisconsin- | Comments Off

Angel Biotechnology – Angel signs new contract with ReNeuron

16 May 2012 Angel Biotechnology Holdings plc (“Angel” or “the Company”) Angel signs new contract with ReNeuron to provide GMP (KOSDAQ: 018290.KQ – news) cell manufacturing services for completion of stroke clinical trial Angel Biotechnology Holdings plc, (AIM:ABH), the biopharmaceutical contract manufacturer, has signed a new contract with ReNeuron Group (Berlin: RQE.BE – news) plc (AIM:RENE) to perform GMP manufacturing services in support of the final part of the PISCES Phase 1 clinical trial of its ReN001 stem cell therapy for stroke; the value of the contract was not disclosed. Continue reading →

Posted in Biotechnology | Tagged a-new-contract, a-real-clinical, angel-biotechnology, clinical-trial, contract, contract-with, director, finance, holdings, information, reaffirms-both, with-additional | Comments Off

Plandai Biotechnology, Inc. Announces Preliminary Agreement With Agriculture Giant, ZZ2, to Produce Highly …

SEATTLE, May 16, 2012 (GLOBE NEWSWIRE) — Plandai Biotechnology, Inc. (OTCBB:PLPL.OB – News), a producer of highly bioavailable botanical extracts, today announced a preliminary agreement with ZZ2, a private farming conglomerate in Southern Africa and the largest producer of fresh tomatoes in the continent of Africa. Continue reading →

Posted in Biotechnology | Tagged agriculture, biotechnology, california, highly-bioavailable, opportunity, partnership, roger-duffield, roman-holdings, southern-africa | Comments Off

Celldex Therapeutics Added to Nasdaq Biotechnology Index

NEEDHAM, Mass.–(BUSINESS WIRE)– Celldex Therapeutics, Inc. (NASDAQ: CLDX – News) today announced that the Company will be added to the NASDAQ Biotechnology Index (NBI), effective prior to market open on Monday, May 21, 2012 Continue reading →

Posted in Biotechnology | Tagged ability, development, expectations, forward, global-market, global-select, ishares, limited, nasdaq, officers-or-key, our-ability, private, release, securities | Comments Off

Infinity Added to NASDAQ Biotechnology Index

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Infinity Pharmaceuticals, Inc. Continue reading →

Posted in Biotechnology | Tagged biotechnology, financial, focused-on-the, hedgehog, infinity, infinity-with, infinitys, intellectual, nasdaq, open-on-monday, pharmaceuticals, press-release-, results-or-from | Comments Off

Global Biotechnology Instrumentation Industry

NEW YORK, May 16, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ This report analyzes the worldwide markets for Biotechnology Instrumentation in US$ Million by the following Product Segments: DNA Synthesizers, Protein/Peptide Synthesizers, DNA Sequencers, Protein/Peptide Sequencers, HPLC Equipment & Supplies, and Electrophoresis Equipment & Supplies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Continue reading →

Posted in Biotechnology | Tagged analytics, biotechnology, dna, equipment, europe, healthcare, japan, reporting-level, synthesizers, york- | Comments Off

TiGenix Reports Business & Financial Results for the First Quarter 2012

LEUVEN, BELGIUM–(Marketwire -05/15/12)- TiGenix NV (TIG) a leader in the field of cell therapy, today gave a business update and announced the financial results for the first quarter ending March 31, 2012. Business highlights Financial highlights “In the first quarter 2012 we continued to aggressively push our commercial efforts forward,” said Eduardo Bravo, CEO of TiGenix. Continue reading →

Posted in Cell Therapy | Tagged a-result-sales, adipose-derived, business, chondro, chondrocelect, european, financial, first, implantation, phase, quarter, same, spain | Comments Off

Gamida Cell Closes $10 Million E Financing Round Earmarked to Support the Global Commercialization of the Company’s …

JERUSALEM–(BUSINESS WIRE)– Gamida Cell announced today that it has closed an internal E financing round of $10 million. All major shareholders participated. The financing will be used to support the global commercialization of the companys lead cell therapy product, StemEx, in development as an alternative therapeutic treatment for patients with blood cancers, such as leukemia and lymphoma, who can be cured by bone marrow transplantation but do not have a matched bone marrow donor Continue reading →

Posted in Cell Therapy | Tagged a-game-changer-, a-matched-bone, a-single-unit, analysis, continued, elbit-imaging, gamida, gamida-cells, market, reuven-krupik, shareholders | Comments Off

Lenalidomide delays progression of multiple myeloma after stem cell transplant

Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. Continue reading →

Posted in Stem Cell Therapy | Tagged a-new-long-term, associated-with, authors-on-the, bone, director, england-journal, lenalidomide, months-or-even, newly-diagnosed, programs-at-unc, study-published, the-progression, thomas-shea, treatment | Comments Off

Lung cancer molecular subtypes correlate with genetic alterations, patient's response to therapy

Published on May 14, 2012 at 12:51 AM Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. Continue reading →

Posted in Genetic medicine | Tagged associated-with, build-on-their, difference, dna, medicine, molecular, north, public, school, science-, science-one-, source, study, these-mutations | Comments Off

:: 14, May 2012 :: SCIENTISTS MAKE GROUNDBREAKING DISCOVERY OF MUTATION CAUSING GENETIC DISORDER IN HUMANS

MEDIA RELEASE SCIENTISTS MAKE GROUNDBREAKING DISCOVERY OF MUTATION CAUSING GENETIC DISORDER IN HUMANS 1. Continue reading →

Posted in Genetic Engineering | Tagged a-birth-defect, a-framework-for, a-single-gene, a-which-affect, adult, function, genetic, media, medical-biology, nature, syndrome, understanding | Comments Off

New Heart Valve Repair System Tested for Safety

(HealthDay News) – A new method of repairing leaking mitral heart valves appears safe, a small study shows. In the new study, researchers tested a reversible implant called the Percutaneous Transvenous Mitral Annuloplasty (PTMA) system, which is installed via a … Continue reading →

Posted in Integrative Medicine | Comments Off

HIV pill Truvada approved by FDA panel for preventative use

Truvada, a popular HIV treatment pill, was approved for preventative use by an FDA panel on Thursday, a milestone in the fight against AIDS. read moreSource:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=preventative+medicine&eo=UTF-8